<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is a <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorder</z:e> inherited as an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> trait and caused by mutations in the gene encoding fibrillin, a 350-kD <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> that multimerizes to form extracellular microfibrils </plain></SENT>
<SENT sid="1" pm="."><plain>It has been unclear whether disease results from a relative deficiency of <z:mp ids='MP_0002169'>wild-type</z:mp> fibrillin; from a dominant-negative effect, in which mutant fibrillin monomers disrupt the function of the <z:mp ids='MP_0002169'>wild-type</z:mp> protein encoded by the <z:mpath ids='MPATH_458'>normal</z:mpath> allele; or from a dynamic and variable interplay between these two pathogenetic mechanisms </plain></SENT>
<SENT sid="2" pm="."><plain>We have now addressed this issue in a cell culture system </plain></SENT>
<SENT sid="3" pm="."><plain>A mutant fibrillin allele from a patient with severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> was expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> human and murine fibroblasts by stable transfection </plain></SENT>
<SENT sid="4" pm="."><plain>Immunohistochemical analysis of the resultant cell lines revealed markedly diminished fibrillin deposition and disorganized microfibrillar architecture </plain></SENT>
<SENT sid="5" pm="."><plain>Pulse-chase studies demonstrated <z:mpath ids='MPATH_458'>normal</z:mpath> levels of fibrillin synthesis but substantially reduced deposition into the extracellular matrix </plain></SENT>
<SENT sid="6" pm="."><plain>These data illustrate that expression of a mutant fibrillin allele, on a background of two <z:mpath ids='MPATH_458'>normal</z:mpath> alleles, is sufficient to disrupt <z:mpath ids='MPATH_458'>normal</z:mpath> microfibrillar assembly and reproduce the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> <z:mp ids='MP_0005384'>cellular phenotype</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>This underscores the importance of the fibrillin amino-terminus in <z:mpath ids='MPATH_458'>normal</z:mpath> microfibrillar assembly and suggests that expression of the human extreme 5' fibrillin coding sequence may be sufficient, in isolation, to produce an animal model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Lastly, this substantiation of a dominant-negative effect offers mutant allele knockout as a potential strategy for gene therapy </plain></SENT>
</text></document>